Investors love data. So why not dig into sustainability metrics?

Odyssey buys BenevolentAI in Europe's top SPAC deal

ALPHA10X : de l’IA pour réduire le risque lié à l’investissement dans les sciences de la vie

Venture capitalists raise more than $100bn to target life sciences

UBS clients raise $650 mln for biggest yet biotech impact fund

Predictive language models' underlying function more closely resembles the human brain

The Heart of AI

Ronald Cohen: “Mesurons l’impact comme on mesure les profits”

Exscientia : Announces Closing of $510.4 Million Aggregate Financing, Consisting of $350.4 Million Upsized Initial Public Offering With Full Exercise of Underwriters' Option to Purchase Additional ADSs and $160.0 Million Concurrent Private Placement

China's industrial heartland embraces artificial intelligence